SSTR positive	Neuroendocrine Tumor	SSTR positive	Neuroendocrine Tumor	lutetium Lu 177 dotatate Sensitive: A1 - Approval lutetium Lu 177 dotatate Sensitive : A1	lutetium Lu 177 dotatate Sensitive: A1 - Approval lutetium Lu 177 dotatate Sensitive : A1
SSTR Expression	Neuroendocrine Tumor	SSTR Expression	Neuroendocrine Tumor	ORM-2110 Sensitive: C3 – Early Trials ORM-2110 Sensitive : C3	ORM-2110 Sensitive: C3 – Early Trials ORM-2110 Sensitive : C3
SSTR positive	Neuroendocrine Tumor	SSTR positive	Neuroendocrine Tumor	RYZ101 Sensitive: C3 – Early Trials RYZ101 Sensitive : C3	RYZ101 Sensitive: C3 – Early Trials RYZ101 Sensitive : C3
SSTR2 overexpression	Small Cell Lung Cancer	SSTR2 overexpression	Small Cell Lung Cancer	RYZ101 Sensitive: D – Preclinical RYZ101 Sensitive : D	RYZ101 Sensitive: D – Preclinical RYZ101 Sensitive : D
SSTR2 underexpression	Neuroendocrine Tumor	SSTR2 underexpression	Neuroendocrine Tumor	lutetium Lu 177 dotatate Sensitive: D – Preclinical lutetium Lu 177 dotatate Sensitive : D	lutetium Lu 177 dotatate Sensitive: D – Preclinical lutetium Lu 177 dotatate Sensitive : D

SSTR2 modulator

Associations(5)